Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr
News

Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr

The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022

  • By IPP Bureau | November 14, 2022

Suven Life Sciences Limited has posted net loss of Rs. 23.18 crores for the period ended September 30, 2022 as against net loss of Rs. 16.32 crores for the period ended June 30, 2022. The company posted net loss of Rs. 28.29  crores for the period ended September 30, 2021.

The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022 as compared to Rs. 3.97 crores during the period ended June 30, 2022. It reported total income of Rs.1.68 crores during the period ended September 30, 2021.

For the six months period ended September 30, 2022, Suven Life Sciences has reported total income of Rs.8.56 crores as compared to Rs.4.5325 crores during the six months period ended September 30, 2021.

The company has posted net loss of Rs. 39.50 crores for the six months period ended September 30, 2022 as against net loss of Rs. 67.50 crores for the six months period ended September 30, 2021.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International